MedPath

Behaviour and Cognitive Evaluation for Dialysis Elderly Patients (BCDE)

Not Applicable
Terminated
Conditions
Chronic Renal Insufficiency
Chronic Kidney Failure
Aged
Registration Number
NCT01225458
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

The trial is a multicenter, prospective, randomized, open study. A total of 500 elderly patients aged over 75 years with renal insufficiency stage 5 will be included in the study after signed informed consent. Patients will be randomized 1/1 in two arms : 250 patients in the "exclusive nephrology follow-up" arm will continue their usual follow-up; 250 patients in the "geriatric follow-up" arm will have both their usual nephrology follow-up and a geriatric follow-up.

The aim of the study is to determine if a systematized gerontologist evaluation delay the occurrence of a composite primary endpoint : death, dementia, depression and severe dependency. The hypothesis is that the functional and vital prognosis of a patient with renal insufficiency depends not only on common and classical factors but also on cognitive and psychological functions and dependence, particularly in elderly patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
48
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
deathevery 6 month for 3 years since inclusion
occurrence of a severe dementia (MMS < 10)every 6 month for 3 years since inclusion
major depression detected by GDS-15 > 10/15 and confirmed by DSM-IV criteriaevery 6 month for 3 years since inclusion
severe dependency (ADL < 3/6)every 6 month for 3 years since inclusion
Secondary Outcome Measures
NameTimeMethod
cognitive, psychic and autonomy scoresevery 6 month for 3 years since inclusion
bone fractureevery 6 month for 3 years since inclusion
nutritional parametersevery 6 month for 3 years since inclusion
dialysis parametersevery 6 month for 3 years since inclusion
cardiovascular morbidity and mortalityevery 6 month for 3 years since inclusion
biological follow-up of chronic kidney disease including haemoglobin levelevery 6 month for 3 years since inclusion

Trial Locations

Locations (1)

CHU de Nice

🇫🇷

Nice, France

CHU de Nice
🇫🇷Nice, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.